Organogenesis Holdings Inc (ORGO) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. ORGO received an overall rating of 77, which means that it scores higher than 77 percent of all stocks. Organogenesis Holdings Inc also achieved a score of 99 in the Drug Manufacturers - Specialty & Generic industry, putting it above 99 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 143 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Organogenesis Holdings Inc Stock Today?
Organogenesis Holdings Inc (ORGO) stock is trading at $17.86 as of 12:51 PM on Tuesday, May 11, a decline of -$1.43, or -7.39% from the previous closing price of $19.29. The stock has traded between $16.97 and $19.36 so far today. Volume today is 790,305 compared to average volume of 764,364.
Click Here to get the full Stock Score Report on Organogenesis Holdings Inc (ORGO) Stock.
